Comarum Palustre in Knee Osteoarthritis and Diabetes
Status:
Completed
Trial end date:
2018-11-25
Target enrollment:
Participant gender:
Summary
The study evaluates analgesic, antiinflammatory and metabolic effects of Comarum palustre in
patients with knee osteoarthritis (OA) and diabetes mellitus. Patients with osteoarthritis
will receive Comarum palustre together with conventional treatment of osteoarthritis and
diabetes.
Phase:
Phase 4
Details
Lead Sponsor:
Federal State Budgetary Scientific Institution, Research Institute of Fundamental and Clinical Immunology